PATENT CLAIM ANALYSIS

Application Number: 16200004
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "254060"]

Abstract:
The invention relates to a method for the treatment of vasomotor symptoms comprising the administration of a therapeutically effective amount of flibanserin.

Claim (Index 18):
A method for the treatment of vasomotor symptoms associated with menopause comprising the oral administration to an adult human patient in need of such treatment of one or more capsule or tablet comprising a therapeutically effective amount of flibanserin, or a pharmacologically acceptable acid addition salt, hydrate or solvate, thereof, and at least one excipient, wherein said vasomotor symptoms are selected from the group consisting of hot flashes, hot flushes, night sweats, mood swings, and irritability.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14583275', '15686665', '12368907', '16125883', '11099155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5843972967191662
- 35 USC 102 Novelty (BERT): 0.5239353807705002
- Combined Prediction Score: 0.5783511051242997
- Mean Citation Score: 232.67160400000003
- Max Citation Score: 325.60278
- Similarity Product: 300.61116218328243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test